Dr. Goldstein describes hypoactive sexual desire disorder and discusses the available treatments.
Hi. I am Irwin Goldstein. I am a sexual medicine physician. I am Director of the Sexual Medicine Program here at Alvarado Hospital in San Diego, California, and I am a EmpowHer Advisory Board member.
If God is good, and that means the FDA, and if the drug company involved has the appropriate application, hopefully some time early next year, probably end of first quarter, the Food and Drug Administration will make some historic announcement that a medication will have been reviewed for its safety information and its efficacy information and deemed acceptable for use in women who have a kind of sexual dysfunction called HSDD, which means Hypoactive Sexual Desire Disorder.
Of all the sexual dysfunctions in women – low interest, can’t arouse, can’t lubricate, dry vagina, poor orgasm, muted orgasm, no pleasure from orgasm, sexual pain – the most common is low interest. So HSDD will have I guess, if this happens, the first ever FDA-approved product for women who have a sexual health concern.
Essentially, its role is to change the chemical balance. In essence, this is the balance and it can tip towards inhibition which these women have, or it can tip towards excitation, which some women have too much excitation. Some women, their genitals are aroused all the time so they are tipped towards excitation. Some women are tipped towards inhibition, and the idea of the medication is to flip the inhibition back to at least a better chance for the woman to excite during the appropriate sexual times.
About Dr. Goldstein, M.D.:
Dr. Irwin Goldstein is Director of San Diego Sexual Medicine at Alvarado Hospital, the Secretary of the International Society for the Study of Women’s Sexual Health, a former President of the Sexual Medicine Society of North America and a Clinical Professor of Surgery at University of California at San Diego.
Dr. Goldstein has been involved with sexual dysfunction research since the late 1970s. His specialties include penile microvascular bypass surgery, surgery for dyspareunia, physiologic investigation of sexual function in men and women, and diagnosis and treatment of sexual dysfunction in men and women.